GRIFOLS reported €1.92B in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Alcon AG ALC:SW 2.25B 225M
Amadeus IT AMS:SM € 1630M 374.3M
Amarin AMRN:US $ 300.57M 70.11M
Artemis Alpha ATS:LN 5.35M 469K
AstraZeneca AZN:LN 22740M 146M
Bayer BAYN:GR € 31019M 1616M
Fresenius FRE:GR € 14138M 924M
Fresenius Medical Care FME:GR € 6377.45M 880.18M
Galapagos GLPG:NA € 562.9M 3.58M
Genmab GEN:DC DK 1339M 229M
GlaxoSmithKline GSK:LN 24278M 608M
GRIFOLS GRF:SM € 1921.48M 360.62M
H. Lundbeck A/S LUN:DC 7.83B 988M
Hikma Pharmaceutical HIK:LN 1.02B 56M
Inditex ITX:SM € 9335M 1305M
Merck MRK:GR € 10207M 225M
Novartis NOVN:VX SF 29807M 401M
William Demant Holding WDH:DC 10.97B 1.5B